XML 141 R77.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
LONG-TERM DEBT AND FINANCE LEASE OBLIGATIONS - Additional Information (Details)
3 Months Ended 12 Months Ended
Jan. 03, 2020
USD ($)
Oct. 23, 2019
USD ($)
Apr. 03, 2018
USD ($)
Mar. 26, 2018
USD ($)
payment
Mar. 31, 2018
USD ($)
Dec. 28, 2019
USD ($)
Dec. 29, 2018
USD ($)
Nov. 04, 2019
USD ($)
Sep. 29, 2018
USD ($)
Feb. 12, 2018
USD ($)
Debt Instrument [Line Items]                    
Weighted average interest rate           3.46% 4.24%      
Bridge Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility                   $ 830,000,000
Capitalized debt issuance costs                 $ 1,800,000  
Fees paid for temporary backstop facility         $ 2,000,000.0          
Letter of Credit                    
Debt Instrument [Line Items]                    
Amount outstanding under letters of credit           $ 7,500,000 $ 6,500,000      
Credit facility | $1.65 Billion Credit Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility       $ 1,650,000,000            
Credit facility | $2.3 Billion Credit Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility       2,300,000,000            
Capitalized debt issuance costs             6,200,000      
Expensed debt issuance costs       1,600,000     1,000,000.0      
Credit facility | Term Loan Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility       $ 750,000,000            
Number of quarterly installment payments | payment       19            
Pre-payments of long-term debt   $ 500,000,000.0                
Credit facility | $1.55 Billion Credit Facility | Multi-currency Revolving Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility               $ 1,550,000,000    
Credit facility | $2.5 Billion Credit Facility                    
Debt Instrument [Line Items]                    
Minimum EBITDA less capital expenditures to consolidated cash interest expense       3.50            
Credit facility | $2.5 Billion Credit Facility | Federal Funds Rate                    
Debt Instrument [Line Items]                    
Interest rate       0.50%            
Credit facility | $2.5 Billion Credit Facility | LIBOR                    
Debt Instrument [Line Items]                    
Interest rate       1.00%            
Credit facility | $2.5 Billion Credit Facility | Multi-currency Revolving Facility                    
Debt Instrument [Line Items]                    
Amount of credit facility               2,050,000,000.00    
Maximum increase to the term loan and/or revolving line of credit               1,000,000,000.0    
Senior Notes | 2028 Senior Notes                    
Debt Instrument [Line Items]                    
Capitalized debt issuance costs   6,000,000       $ 500,000        
Proceeds from private offering of debt   500,000,000.0                
Aggregate principal amount   $ 500,000,000           $ 500,000,000.0    
Maximum consolidated indebtedness to consolidated EBITDA, with step downs               4.00    
Stated interest rate           4.25%        
Redemption price percentage, conditional upon equity offerings   40.00%                
Redemption price percentage in the event of a change of control   101.00%                
Net proceeds from debt   $ 494,000,000                
Senior Notes | 2028 Senior Notes | Redemption Period One                    
Debt Instrument [Line Items]                    
Redemption price percentage   100.00%                
Senior Notes | 2028 Senior Notes | Redemption Period Two                    
Debt Instrument [Line Items]                    
Redemption price percentage   104.25%                
Senior Notes | 2026 Senior Notes                    
Debt Instrument [Line Items]                    
Capitalized debt issuance costs     $ 7,400,000              
Aggregate principal amount     $ 500,000,000              
Stated interest rate           5.50%        
Redemption price percentage, conditional upon equity offerings     40.00%              
Redemption price percentage in the event of a change of control     101.00%              
Net proceeds from debt     $ 493,800,000              
Senior Notes | 2026 Senior Notes | Redemption Period One                    
Debt Instrument [Line Items]                    
Redemption price percentage     100.00%              
Senior Notes | 2026 Senior Notes | Redemption Period Two                    
Debt Instrument [Line Items]                    
Redemption price percentage     105.50%              
Minimum | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Foreign exchange forward contract amount           $ 300,000,000        
Maximum | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Foreign exchange forward contract amount           400,000,000        
HemaCare Corporation | Subsequent Event                    
Debt Instrument [Line Items]                    
Purchase price $ 380,000,000                  
Other income, net | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Foreign currency translation loss recognized           9,600,000 100,000      
Amount of gain (loss)           (121,000)        
Interest expense | Foreign Exchange Forward                    
Debt Instrument [Line Items]                    
Amount of gain (loss)           $ 18,672,000 $ 1,486,000